Xeris Biopharma (XERS) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.06
-0.04
-0.01
0.01

Details

Expected EPS
-0.002743
Actual EPS
0.01
Surprise EPS
0.01
Surprise Percent
+464.56%

Description

⁨Xeris Biopharma⁩ (⁦XERS⁩) has reported earnings of ⁦0.01⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts